By vgreene, 27 April, 2020 No drugs or other therapeutics presently FDA-approved to treat or prevent COVID-19
By vgreene, 27 April, 2020 NIH has published interim guidelines for medical mgmt that include info on investigational therapies
By vgreene, 27 April, 2020 Current mgmt included infxn prevention/control and supportive care, incl supplemental O2 and mechanical ventilation when indicated
By vgreene, 27 April, 2020 Who to test? Priority: 1) Persons w/ sx of potential COVID-19 infxn, incl fever, cough, SOB, chills, myalgia, new loss of taste/smell, vomiting and/or diarrhea, sore throat 2) Asymptomatic persons prioritized by public health depts or clinicians, for any
By vgreene, 27 April, 2020 CDC Preparedness Tools for Healthcare Professionals and Facilities Responding to Coronavirus (COVID-19)
By vgreene, 27 April, 2020 Generally minimal/transient adverse effects, incl ear fullness, nasal mucosa stinging, rarely epistaxis15
By vgreene, 27 April, 2020 Protozoa infection. Primary amebic meningoencephalitis w/ Naegleria fowleri,11,12 cerebral Balamuthia mandrillaris13 reported from unboiled tap water nasal irrigation. Only sterile, distilled, or previously boiled water should be used14